BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jiang QY, Chen ZX, Zhang S, Xue RY. Future therapies for pancreatic carcinoma: Insights into cancer precision medicine. World J Gastroenterol 2022; 28(22): 2523-2526 [PMID: 35979258 DOI: 10.3748/wjg.v28.i22.2523]
URL: https://www.wjgnet.com/1948-5204/full/v28/i22/2523.htm
Number Citing Articles
1
Shuangyan Su, Bihua Wu, Tingting Han, XianYu Wang, Fenglin Lou, Zhenghao Mei, Le Guo. Identification of the disulfidptosis-related gene G6PD as a potential biomarker and therapeutic target in pancreatic ductal adenocarcinoma by integrative bioinformatics analysis and experimental validationDiscover Oncology 2026;  doi: 10.1007/s12672-026-04753-3
2
Zhenxiong Xie, Lin Ji, Fang Wu, Hui Cao. miR-34c-3p targets FOXO3 to promote pancreatic carcinoma progressionNucleosides, Nucleotides & Nucleic Acids 2025; : 1 doi: 10.1080/15257770.2025.2537167